The Microbiota-Gut-Brain Axis: Clinical Applications in Obesity and Type 2 Diabetes
Rev. invest. clín
; 74(6): 302-313, Nov.-Dec. 2022. graf
Article
in En
|
LILACS-Express
| LILACS
| ID: biblio-1431819
Responsible library:
MX1.1
ABSTRACT
ABSTRACT Recent investigations highlight the importance of the gut microbiota and bacteria-derived metabolites as key components in obesity and metabolic health. The microbiota-gut-brain axis presents promising targets for future obesity treatments and prevention. However, the current state of evidence and existing clinical applications of the microbiota-gut-brain axis have yet to be summarized in a thorough review. Therefore, we sought to examine current evidence on the effect of lifestyle, dietary, pharmacological, and surgical interventions on the microbiota-gut-brain axis. In addition, this review highlights potential next steps in research toward characterizing the role of the microbiota-gut-brain axis in metabolic health, along with possible interventions to address obesity.
Full text:
1
Collection:
01-internacional
Database:
LILACS
Language:
En
Journal:
Rev. invest. clín
Journal subject:
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Mexico